| Entry |
|
|---|
| Name |
Budipine hydrochloride;
Parkinsan (TN) |
|---|
| Formula |
C21H27N. HCl
|
|---|
| Exact mass |
329.191
|
|---|
| Mol weight |
329.9067
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BX Other dopaminergic agents
N04BX03 Budipine
D07589 Budipine hydrochloride
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D07589 Budipine hydrochloride
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 23
1 C8x C 20.5100 -20.0200
2 C8x C 20.5100 -21.4200
3 C8x C 21.7000 -22.1200
4 C8x C 22.9600 -21.4200
5 C8y C 22.9600 -20.0200
6 C8x C 21.7000 -19.3200
7 C1z C 24.1500 -19.3200
8 C8y C 25.3400 -20.0200
9 C8x C 25.3400 -21.4200
10 C8x C 26.6000 -22.1200
11 C8x C 27.7900 -21.4200
12 C8x C 27.7900 -20.0200
13 C8x C 26.6000 -19.3200
14 C1x C 25.3400 -18.6200
15 C1x C 25.3400 -17.2200
16 N1y N 24.1500 -16.5200
17 C1x C 22.9600 -17.2200
18 C1x C 22.9600 -18.6200
19 C1d C 24.1500 -15.1200
20 C1a C 24.1500 -13.7200
21 C1a C 22.7500 -15.1200
22 C1a C 25.5500 -15.1200
23 X Cl 29.4700 -18.6200
BOND 24
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 7 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 7 18 1
21 16 19 1
22 19 20 1
23 19 21 1
24 19 22 1
|
|---|
